Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1377541548;41549;41550 chr2:178636404;178636403;178636402chr2:179501131;179501130;179501129
N2AB1213436625;36626;36627 chr2:178636404;178636403;178636402chr2:179501131;179501130;179501129
N2A1120733844;33845;33846 chr2:178636404;178636403;178636402chr2:179501131;179501130;179501129
N2B471014353;14354;14355 chr2:178636404;178636403;178636402chr2:179501131;179501130;179501129
Novex-1483514728;14729;14730 chr2:178636404;178636403;178636402chr2:179501131;179501130;179501129
Novex-2490214929;14930;14931 chr2:178636404;178636403;178636402chr2:179501131;179501130;179501129
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTA
  • RefSeq wild type template codon: CAT
  • Domain: Ig-87
  • Domain position: 92
  • Structural Position: 176
  • Q(SASA): 0.798
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/E None None 1.0 D 0.756 0.841 0.905287540064 gnomAD-4.0.0 1.61995E-06 None None None None I None 0 0 None 0 0 None 0 0 2.90757E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.7955 likely_pathogenic 0.7964 pathogenic -1.407 Destabilizing 0.999 D 0.727 prob.delet. D 0.762547304 None None I
V/C 0.9741 likely_pathogenic 0.9712 pathogenic -0.987 Destabilizing 1.0 D 0.807 deleterious None None None None I
V/D 0.996 likely_pathogenic 0.9956 pathogenic -1.202 Destabilizing 1.0 D 0.757 deleterious None None None None I
V/E 0.9835 likely_pathogenic 0.9826 pathogenic -1.068 Destabilizing 1.0 D 0.756 deleterious D 0.761821382 None None I
V/F 0.8354 likely_pathogenic 0.8258 pathogenic -0.723 Destabilizing 1.0 D 0.802 deleterious None None None None I
V/G 0.9284 likely_pathogenic 0.9235 pathogenic -1.854 Destabilizing 1.0 D 0.719 prob.delet. D 0.761821382 None None I
V/H 0.9943 likely_pathogenic 0.9945 pathogenic -1.397 Destabilizing 1.0 D 0.754 deleterious None None None None I
V/I 0.1262 likely_benign 0.1362 benign -0.225 Destabilizing 0.997 D 0.703 prob.neutral D 0.580578592 None None I
V/K 0.973 likely_pathogenic 0.9764 pathogenic -1.192 Destabilizing 1.0 D 0.763 deleterious None None None None I
V/L 0.7316 likely_pathogenic 0.729 pathogenic -0.225 Destabilizing 0.997 D 0.731 prob.delet. D 0.634599555 None None I
V/M 0.727 likely_pathogenic 0.7295 pathogenic -0.282 Destabilizing 1.0 D 0.826 deleterious None None None None I
V/N 0.9853 likely_pathogenic 0.9844 pathogenic -1.277 Destabilizing 1.0 D 0.769 deleterious None None None None I
V/P 0.9837 likely_pathogenic 0.9788 pathogenic -0.585 Destabilizing 1.0 D 0.776 deleterious None None None None I
V/Q 0.978 likely_pathogenic 0.9767 pathogenic -1.213 Destabilizing 1.0 D 0.788 deleterious None None None None I
V/R 0.9569 likely_pathogenic 0.9598 pathogenic -0.945 Destabilizing 1.0 D 0.773 deleterious None None None None I
V/S 0.9459 likely_pathogenic 0.9406 pathogenic -1.921 Destabilizing 1.0 D 0.746 deleterious None None None None I
V/T 0.8005 likely_pathogenic 0.7995 pathogenic -1.65 Destabilizing 0.999 D 0.769 deleterious None None None None I
V/W 0.996 likely_pathogenic 0.9957 pathogenic -1.087 Destabilizing 1.0 D 0.727 prob.delet. None None None None I
V/Y 0.986 likely_pathogenic 0.9854 pathogenic -0.692 Destabilizing 1.0 D 0.809 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.